Can You Take Carbamazepine and Voriconazole Together?

No. According to FDA drug labeling and the NIH/NLM reference system, carbamazepine and voriconazole together are classified as contraindicated—meaning the combination is not recommended because carbamazepine significantly reduces how much voriconazole reaches your bloodstream. This reduction can make voriconazole ineffective at treating a fungal infection. If you are taking both medications or are considering doing so, you must discuss alternatives with your healthcare provider and pharmacist before making any changes.

What the Source Says

The documented interaction record, sourced from voriconazole FDA drug labeling and curated through the NIH/NLM RxNorm database, states:

• Severity: Contraindicated
• Mechanism: CYP450 Induction
• Clinical Effect: Carbamazepine is a CYP450 enzyme inducer likely to result in a significant reduction of voriconazole plasma exposure
• Source: FDA drug labeling for voriconazole

This classification reflects published clinical evidence that the combination carries unacceptable risk and is contraindicated under standard prescribing guidelines. The source material does not provide a specific incidence rate or degree-of-reduction measurement, but the "contraindicated" severity level indicates that the risk of treatment failure from reduced drug exposure is deemed clinically significant.

How to Understand This Interaction

To understand why this interaction happens and why it matters, it helps to know a little about how the body processes both drugs.

What Voriconazole Does: Voriconazole is an antifungal medication used to treat serious infections caused by fungi, including aspergillosis and other invasive fungal infections. For the drug to work, it must be absorbed into the bloodstream and reach the site of infection at a high enough concentration to kill or inhibit the fungus. If the blood level of voriconazole drops significantly, the drug may not reach a therapeutic concentration—that is, a high enough level to be effective.

How Carbamazepine Interferes: Carbamazepine is an anticonvulsant and mood-stabilizing medication. One of its important properties is that it acts as a CYP450 enzyme inducer. The cytochrome P450 system is a family of liver enzymes responsible for breaking down (metabolizing) hundreds of medications. When carbamazepine induces these enzymes, it speeds up the liver's metabolism of other drugs that use the same enzymatic pathway, including voriconazole.

The Documented Mechanism: According to the source record, carbamazepine induces CYP450 enzymes in a way that significantly increases the breakdown of voriconazole. This faster metabolism means less voriconazole circulates in the bloodstream. Lower voriconazole levels mean lower antifungal effect and a greater risk that the infection will not respond to treatment. Because the expected reduction in voriconazole exposure is substantial, the combination is classified as contraindicated rather than merely requiring caution or dose adjustment.

Why Contraindicated, Not Just "Use With Caution"?: The FDA classification of "contraindicated" is more restrictive than "use with caution" or "monitor carefully." It signals that the prescribers and the FDA believe the risk is too great to manage safely with routine monitoring or dose adjustment alone. The magnitude of enzyme induction by carbamazepine is such that simply raising the voriconazole dose may not be a reliable solution, in part because the dose relationship between the inducer and the affected drug is unpredictable and because other safety considerations may limit dose increases.

Who Should Pay Particular Attention

Anyone who has been prescribed both carbamazepine and voriconazole, or who is considering starting one while on the other, needs to alert their healthcare provider immediately. This includes:

• Patients with seizure disorders who are taking carbamazepine for epilepsy and who develop a serious fungal infection
• Patients taking carbamazepine for bipolar disorder or other psychiatric conditions who need antifungal treatment
• Patients with chronic fungal infections who are subsequently started on carbamazepine
• Anyone in a hospital or outpatient setting where multiple medications are being managed by different specialists

The broader principle is that any patient on a CYP450-inducing medication who requires an antifungal should have that regimen reviewed by a pharmacist and physician to identify and manage such interactions proactively.

Hypothetical Examples

Hypothetical Scenario 1: A patient with epilepsy is well-controlled on carbamazepine. During routine imaging, a fungal infection in the lungs (aspergillosis) is discovered. The treating physician wants to prescribe voriconazole, which is a first-line treatment for this infection. However, because the patient is already on carbamazepine, the combination is contraindicated. The physician and pharmacist must consider alternative antifungals (such as liposomal amphotericin B or posaconazole, if appropriate) that may not interact as severely, or explore whether the carbamazepine can be temporarily replaced with another anticonvulsant that does not induce CYP450 enzymes. This kind of medication review can prevent treatment failure and protect the patient's seizure control simultaneously.

Hypothetical Scenario 2: A patient on a stable regimen of carbamazepine for bipolar disorder presents to the emergency department with signs of a serious fungal infection. The emergency team may initially want to start voriconazole for rapid coverage but must first check the patient's home medication list. Upon discovering carbamazepine, they consult the pharmacy and either choose a different antifungal or, if voriconazole is deemed medically necessary, work with the patient's psychiatrist to consider whether the carbamazepine can be safely transitioned to a non-inducing alternative. These decisions are complex and require coordination among multiple providers.

What to Discuss With a Pharmacist or Physician

If you are currently taking both carbamazepine and voriconazole, or if you have been prescribed carbamazepine and your healthcare provider is considering voriconazole (or vice versa), bring the following questions to your appointment:

• "Are there alternative antifungal medications that do not interact with carbamazepine?" Your pharmacist can review whether other antifungals (such as liposomal amphotericin B, posaconazole, isavuconazole, or others) might be appropriate for your infection and your specific clinical situation.
• "Is my carbamazepine essential right now, or could it be temporarily replaced with a non-inducing anticonvulsant or mood stabilizer?" Some antiepileptic and psychiatric medications do not induce CYP450 enzymes to the same degree. A switch may be possible depending on your diagnosis and seizure/mood control.
• "If voriconazole is the only suitable antifungal and carbamazepine cannot be changed, what is the plan?" In rare cases, a healthcare team may decide that the combination is necessary despite the risk. This would require close monitoring, possibly increased voriconazole dosing (if safe), and frequent follow-up. Make sure you understand the monitoring plan if this is the case.
• "What signs of treatment failure should I watch for?" If the combination cannot be avoided, ask what symptoms or test results would indicate that voriconazole is not working—for example, persistent fever, worsening imaging, or negative culture results—so you can report them promptly.
• "How often should my blood levels or clinical status be checked?" If the combination must be used, clarify the monitoring schedule with your healthcare provider.

Do not stop, skip, substitute, or change either medication on your own. All medication decisions must be made in consultation with your prescribers and pharmacist, especially when a documented contraindication is involved.

Key Takeaways

• Carbamazepine and voriconazole are classified as contraindicated by FDA drug labeling because carbamazepine is a potent CYP450 enzyme inducer that significantly reduces voriconazole blood levels.
• Lower voriconazole exposure means the antifungal drug may not reach a high enough concentration to treat a fungal infection effectively, putting you at risk of treatment failure.
• If you are taking both medications or your healthcare provider is considering prescribing both, alert all your doctors and pharmacists immediately so they can review alternatives or develop a closely monitored plan.
• Possible solutions include switching to an alternative antifungal that does not interact as severely with carbamazepine, or—if medically feasible—temporarily replacing carbamazepine with an anticonvulsant or mood stabilizer that does not induce CYP450 enzymes.
• This interaction illustrates the importance of comprehensive medication review, especially when managing complex conditions that require multiple specialist medications.

Sources

• DailyMed (FDA Drug Labeling Database) — The authoritative source for FDA-approved drug information, including prescribing information for voriconazole and carbamazepine.
• RxNorm (NIH/NLM) — The reference standard for drug names and interaction data used by checkdruginteractions.com.
• Open FDA — A public repository of FDA drug labeling, adverse events, and regulatory information.
• PubMed (NIH/NLM) — A database of peer-reviewed medical literature on drug interactions and clinical outcomes. Search "carbamazepine CYP450 induction" or "voriconazole drug interaction" to find supporting studies.

The interaction record sourced for this article is based on FDA drug labeling for voriconazole as curated in the NIH/NLM RxNorm database. Because this is a documented contraindication, the clinical evidence supporting it is considered robust and the recommendation is not to use this pair together without explicit clinical justification and close coordination between all prescribers.

Check Your Medications and Consult Your Healthcare Team

If you are taking carbamazepine, voriconazole, or both, take a moment to review your full medication list at checkdruginteractions.com. The site allows you to enter all your current medications and identify potential interactions before they become a clinical problem. However, no online tool can replace a conversation with your pharmacist or physician. Use this article and the checkdruginteractions.com results as a starting point for that conversation, not as a substitute for professional medical advice. Your healthcare team has access to your complete medical history and can make personalized decisions that balance the risks and benefits of your specific situation. If you have questions about whether carbamazepine and voriconazole are safe for you, or if you need help finding alternatives, schedule an appointment with your prescriber and pharmacist today.